SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022720
Filing Date
2017-11-08
Accepted
2017-11-08 16:03:23
Documents
65
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-10q_20170930.htm 10-Q 1132792
2 EX-10.2 crsp-ex102_310.htm EX-10.2 40693
3 EX-10.3 crsp-ex103_311.htm EX-10.3 39466
4 EX-10.4 crsp-ex104_312.htm EX-10.4 34774
5 EX-10.5 crsp-ex105_313.htm EX-10.5 28830
6 EX-10.6 crsp-ex106_314.htm EX-10.6 25465
7 EX-10.7 crsp-ex107_315.htm EX-10.7 24464
8 EX-31.1 crsp-ex311_8.htm EX-31.1 15819
9 EX-31.2 crsp-ex312_6.htm EX-31.2 15849
10 EX-32.1 crsp-ex321_7.htm EX-32.1 7759
  Complete submission text file 0001564590-17-022720.txt   4886595

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT crsp-20170930.xml EX-101.INS 908364
12 XBRL TAXONOMY EXTENSION SCHEMA crsp-20170930.xsd EX-101.SCH 42937
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crsp-20170930_cal.xml EX-101.CAL 41360
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crsp-20170930_def.xml EX-101.DEF 170914
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20170930_lab.xml EX-101.LAB 342419
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20170930_pre.xml EX-101.PRE 264463
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 171186542
SIC: 2836 Biological Products, (No Diagnostic Substances)